| Followers | 131 |
| Posts | 15004 |
| Boards Moderated | 0 |
| Alias Born | 06/04/2018 |
Friday, July 05, 2019 1:10:26 PM
News: $CTRV NetworkNewsBreaks - ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Closes $15.6M Underwritten Public Offering
ContraVir Pharmaceuticals (NASDAQ: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral infection, has closed an underwritten public offering res...
Read the whole news NetworkNewsBreaks - ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Closes $15.6M Underwritten Public Offering
ContraVir Pharmaceuticals (NASDAQ: CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”) and chronic viral infection, has closed an underwritten public offering res...
Read the whole news NetworkNewsBreaks - ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Closes $15.6M Underwritten Public Offering
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 09:00:12 PM
- Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq • GlobeNewswire Inc. • 05/12/2025 08:30:00 PM
- Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC • GlobeNewswire Inc. • 05/07/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:59:37 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/23/2025 08:05:48 PM
